The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
Open accessAbstract
Fungal pathogens form biofilms that are highly recalcitrant to antimicrobial therapy. The expression of multidrug resistance pumps in young biofilms has been linked to increased resistance to azoles, but this mechanism does not seem to underlie the resistance of mature biofilms that is a model of in vivo infection. The mechanism of drug resistance of mature biofilms remains largely unknown. We report that biofilms formed by the major human pathogen Candida albicans exhibited a strikingly biphasic killing pattern in response to two microbicidal agents, amphotericin B, a polyene antifungal, and chlorhexidine, an antiseptic, indicating that a subpopulation of highly tolerant cells, termed persisters, existed. The extent of killing with a combination of amphotericin B and chlorhexidine was similar to that observed with individually added antimicrobials. Thus, surviving persisters form a multidrug-tolerant subpopulation. Interestingly, surviving C. albicans persisters were detected only in biofilms and not in exponentially growing or stationary-phase planktonic populations. Reinoculation of cells that survived killing of the biofilm by amphotericin B produced a new biofilm with a new subpopulation of persisters. This suggests that C. albicans persisters are not mutants but phenotypic variants of the wild type. Using a stain for dead cells, rare dark cells were visible in a biofilm after amphotericin B treatment, and a bright and a dim population were physically sorted from this biofilm. Only the dim cells produced colonies, showing that this method allows the isolation of yeast persisters. Given that persisters formed only in biofilms, mutants defective in biofilm formation were examined for tolerance of amphotericin B. All of the known mutants affected in biofilm formation were able to produce normal levels of persisters. This finding indicates that attachment rather than formation of a complex biofilm architecture initiates persister formation. Bacteria produce multidrug-tolerant persister cells in both planktonic and biofilm populations, and it appears that yeasts and bacteria have evolved analogous strategies that assign the function of survival to a small part of the population. In bacteria, persisters are dormant cells. It remains to be seen whether attachment initiates dormancy that leads to the formation of fungal persisters. This study suggests that persisters may be largely responsible for the multidrug tolerance of fungal biofilms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Currently, antifungal persistence is mainly identified in Candida-associated biofilms [2,32,33].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antifungal persistence is most commonly observed in biofilm rather than in planktonic cells [2,33,34]”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“To solve these problems, live/dead staining method can be applied because of its ability to distinguish live/dead cells, which reflects the essence of persisters that survive exposure to fungicides.”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“For example, C. albicans persister biofilms are recalcitrant to AmB and broad-spectrum antimicrobial agent chlorhexidine [2];”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“indicating that antifungal persistence is not solely dependent on matured biofilm structure formation [2].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“However, LaFleur and colleagues first reported that the biofilm-deficient double mutant strain efg1Δ/cph1Δ did not result in the reduction of AmB-triggered persisters”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [2]
In the citing paper
“Inside the biofilm cell population, persister cells form a unique group that is formed randomly, phenotypically dormant, highly tolerant to antifungal drugs [164], and which is a key mechanism of resistance in chronic infections [130].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [164]
In the citing paper
“A minor subset of metabolically dormant yeast cells that stochastically arise as phenotypical variants within biofilms, persister cells are extremely resistant to antifungal drugs (100).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [100]
In the citing paper
“Although we know little about the formation and roles of persister cells in C. albicans biofilms, we do know that the drug resistance of persister cells is independent of cell membrane composition and efflux pump expression; rather, it is the result of the metabolically dormant state of the cells (88, 100).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A. L., Wang, Y., & Lewis, K. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,094
Self-citationCandida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 907
Self-citationSpecialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A. L., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 848
Self-citationKuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 775
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678
Research works printed but not linked: 1
- 10.1111/j.1574-6968.2002.tb11330.x · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 519
Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole
Bink, A., Vandenbosch, D., Coenye, T., Nelis, H., Cammue, B. P. A., & Thevissen, K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-11 · Cited by 119
“Persisters”: Survival at the Cellular Level
Dawson, C. C., Intapa, C., & Jabra‐Rizk, M. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002121 · Cited by 125
Biofilm Formation by Cryptococcus neoformans
Martinez, L. R., & Casadevall, A. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0006-2014 · Cited by 119
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence
Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118
The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris
Rossoni, R. D., de Barros, P. P., Mendonça, I. D. C., Medina, R. P., Silva, D. H. S., Fuchs, B. B., Junqueira, J. C., & Mylonakis, E. E. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00397 · Cited by 118
Fungal Biofilms: Relevance in the Setting of Human Disease
Martinez, L. R., & Fries, B. C. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0035-5 · Cited by 121
Khan, M. S., & Ahmad, I. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.01.045 · Cited by 113
The Transcriptional Regulator Nrg1p Controls Candida albicans Biofilm Formation and Dispersion
Uppuluri, P., Pierce, C. G., Thomas, D. P., Bubeck, S. S., Saville, S. P., & Lopez-Ribot, J. L. (2010) · Eukaryotic Cell · doi:10.1128/ec.00111-10 · Cited by 110
Pusateri, C. R., Monaco, E. A., & Edgerton, M. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.01.016 · Cited by 109
Cell Density and Cell Aging as Factors Modulating Antifungal Resistance ofCandida albicansBiofilms
Seneviratne, C. J., Jin, L., Samaranayake, Y. H., & Samaranayake, L. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00541-08 · Cited by 107
Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms
Mitchell, K. F., Taff, H. T., Cuevas, M. A., Reinicke, E. L., Sanchez, H., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02378-12 · Cited by 104
Absence of Amphotericin B-Tolerant Persister Cells in Biofilms of Some Candida Species
Al-Dhaheri, R. S., & Douglas, L. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-07 · Cited by 99
de Alteriis, E., Maselli, V., Falanga, A., Galdiero, S., Lella, F. M. D., Gesuele, R., Guida, M., & Galdiero, E. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s164262 · Cited by 99
Targeting bacterial energetics to produce new antimicrobials
Hards, K., & Cook, G. M. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.11.001 · Cited by 102
Denture contamination by yeasts in the elderly
Abbeele, A. V., de Meel, H., Ahariz, M., Perraudin, J. P., Beyer, I., & Courtois, P. (2008) · Gerodontology · doi:10.1111/j.1741-2358.2007.00247.x · Cited by 98
Candida and its dual lifestyle as a commensal and a pathogen
Cauchie, M., Desmet, S., & Lagrou, K. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.02.005 · Cited by 101
Biofilm Formation by Pneumocystis spp
Cushion, M. T., Collins, M. S., & Linke, M. J. (2009) · Eukaryotic Cell · doi:10.1128/ec.00202-08 · Cited by 96
Li, P., Seneviratne, C. J., Alpi, E., Vizcaino, J. A., & Jin, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-15 · Cited by 95
Candida albicans Biofilm Development and Its Genetic Control
Desai, J. V., & Mitchell, A. P. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0005-2014 · Cited by 94
Spaceflight Enhances Cell Aggregation and Random Budding in Candida albicans
Crabbé, A., Nielsen‐Preiss, S. M., Woolley, C. M., Barrila, J., Buchanan, K. L., McCracken, J., Inglis, D. O., Searles, S. C., Nelman-Gonzalez, M. A., Ott, C. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080677 · Cited by 96
Chang, W., Liu, J., Zhang, M., Shi, H., Zheng, S., Jin, X., Gao, Y., Wang, S., Ji, A., & Lou, H. (2018) · Nature Communications · doi:10.1038/s41467-018-07633-9 · Cited by 91
Hidden killers: persistence of opportunistic fungal pathogens in the human host
d’Enfert, C. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.05.008 · Cited by 90
The Extracellular Matrix of Fungal Biofilms
Mitchell, K. F., Żarnowski, R., & Andes, D. R. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_6 · Cited by 93
Лахтин, М. В., Aleshkin, V. A., Лахтин, В. М., Afanasiev, S. S., Pozhalostina, L. V., & Pospelova, V. V. (2010) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-010-9046-3 · Cited by 86
Aneuploidy underlies a multicellular phenotypic switch
Tan, Z., Hays, M., Cromie, G. A., Jeffery, E. W., Scott, A. C., Ahyong, V., Sirr, A., Skupin, A., & Dudley, A. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301047110 · Cited by 85
Ferreira, J. A., Carr, J. H., Starling, C. E. F., de Resende, M. A., & Donlan, R. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00316-09 · Cited by 84
Apoptosis in Candida biofilms exposed to amphotericin B
Al-Dhaheri, R. S., & Douglas, L. J. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.015784-0 · Cited by 81
Biofilm Specific Activity: A Measure to Quantify Microbial Biofilm
Corte, L., Pierantoni, D. C., Tascini, C., Roscini, L., & Cardinali, G. (2019) · Microorganisms · doi:10.3390/microorganisms7030073 · Cited by 80
Niemirowicz, K., Durnaś, B., Tokajuk, G., Głuszek, K., Wilczewska, A. Z., Misztalewska‐Turkowicz, I., Mystkowska, J., Michalak, G., Sodo, A., Wątek, M., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.07.006 · Cited by 80
Sensitization of Candida albicans biofilms to fluconazole by terpenoids of plant origin
Doke, S. K., Raut, J. S., Dhawale, S. C., & Karuppayil, S. M. (2014) · The Journal of General and Applied Microbiology · doi:10.2323/jgam.60.163 · Cited by 79
Host–pathogen interactions and virulence-associated genes during Candida albicans oral infections
Martin, R., Wächtler, B., Schaller, M., Wilson, D., & Hube, B. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.04.009 · Cited by 85
Qu, Y., Daley, A. J., Istivan, T. S., Rouch, D. A., & Deighton, M. A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq119 · Cited by 78
Future directions for anti-biofilm therapeutics targetingCandida
Nett, J. E. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.885838 · Cited by 80
Wu, X., Zhang, S., Li, H., Shen, L., Dong, C., Sun, Y., Chen, H., Xu, B., Zhuang, W., Deighton, M. A., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01117 · Cited by 80
Proteomics of drug resistance in Candida glabrata biofilms
Seneviratne, C. J., Wang, Y., Jin, L., Abiko, Y., & Samaranayake, L. P. (2010) · PROTEOMICS · doi:10.1002/pmic.200900611 · Cited by 74
Bonincontro, G., Scuderi, S. A., Marino, A., & Simonetti, G. (2023) · Pharmaceuticals · doi:10.3390/ph16111531 · Cited by 78
Biofilm formation by oral clinical isolates of Candida species
Sánchez-Vargas, L. O., Estrada-Barraza, D., Pozos‐Guillén, A., & Rivas-Caceres, R. (2013) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2013.06.006 · Cited by 74
Harrison, J. J., Ceri, H., Yerly, J., Rabiei, M., Hu, Y., Martinuzzi, R. J., & Turner, R. J. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02711-06 · Cited by 74
Combination Therapy to Treat Fungal Biofilm-Based Infections
Tits, J., Cammue, B. P. A., & Thevissen, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228873 · Cited by 71
Sousa, M., Machado, I., Simões, L. C., & Simões, M. V. (2025) · Environmental Science and Ecotechnology · doi:10.1016/j.ese.2025.100557 · Cited by 72
Rane, H. S., Bernardo, S. M., Howell, A. B., & Lee, S. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt398 · Cited by 69
Social Interactions in the Burkholderia Cepacia Complex: Biofilms and Quorum Sensing
Coenye, T. (2010) · Future Microbiology · doi:10.2217/fmb.10.68 · Cited by 71
Adhesion of bacteria to surfaces and biofilm formation on medical devices
Floyd, K. A., Eberly, A. R., & Hadjifrangiskou, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100382-4.00003-4 · Cited by 71
Rajkowska, K., Nowicka-Krawczyk, P. B., & Kunicka‐Styczyńska, A. (2019) · Molecules · doi:10.3390/molecules24101954 · Cited by 68
Fungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 69
Persister cells: formation, resuscitation and combative therapies
Wainwright, J., Hobbs, G., & Nakouti, I. (2021) · Archives of Microbiology · doi:10.1007/s00203-021-02585-z · Cited by 67
Wang, X., You, J., King, J. B., Powell, D. R., & Cichewicz, R. H. (2012) · Journal of Natural Products · doi:10.1021/np2009994 · Cited by 66
Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625
Galdiero, E., de Alteriis, E., De Natale, A., D’Alterio, A., Siciliano, A., Guida, M., Lombardi, L., Falanga, A., & Galdiero, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-62746-w · Cited by 65
Assessment and Optimizations of Candida albicans In Vitro Biofilm Assays
Lohse, M. B., Gulati, M., Arevalo, A. V., Fishburn, A. T., Johnson, A. D., & Nobile, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02749-16 · Cited by 68
Rao, H., Choo, S., Mahalingam, S. R. R., Adisuri, D. S., Madhavan, P., Akim, A. M., & Chong, P. P. (2021) · Molecules · doi:10.3390/molecules26071870 · Cited by 64
Fungal biofilm inhibitors from a human oral microbiome-derived bacterium
Wang, X., Du, L., You, J., King, J. B., & Cichewicz, R. H. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06856g · Cited by 67
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 69
Photodynamic inactivation of clinical isolates ofCandidausing Photodithazine®
Dovigo, L. N., Carmello, J. C., Carvalho, M. T., Mima, E. G. D. O., Vergani, C. E., Bagnato, V. S., & Pavarina, A. C. (2013) · Biofouling · doi:10.1080/08927014.2013.827668 · Cited by 63
Smith, A., Kaczmar, A., Bamford, R. A., Smith, C., Frustaci, S., Kovacs-Simon, A., O’Neill, P., Moore, K., Paszkiewicz, K. H., Titball, R. W., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01739 · Cited by 67
Characteristics of Candida albicans Biofilms Grown in a Synthetic Urine Medium
Uppuluri, P., Dinakaran, H., Thomas, D. P., Chaturvedi, A. K., & Lopez-Ribot, J. L. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01377-09 · Cited by 62
Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
Nett, J. E., & Andes, D. R. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0008-2014 · Cited by 68
Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence
Alanio, A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136223 · Cited by 62
Semighini, C. P., Averette, A. F., Perfect, J. R., & Heitman, J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002364 · Cited by 61
Sav, H., Rafati, H., Öz, Y., Cılo, B. D., Ener, B., Mohammadi, F., İlkit, M., van Diepeningen, A., & Seyedmousavi, S. (2018) · Journal of Fungi · doi:10.3390/jof4010016 · Cited by 60
LaFleur, M. D., Lucumi, E., Napper, A. D., Diamond, S. L., & Lewis, K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq530 · Cited by 59
Self-citationPhenotypic heterogeneity in fungi: Importance and methodology
Hewitt, S. K., Foster, D. S., Dyer, P. S., & Avery, S. V. (2016) · Fungal Biology Reviews · doi:10.1016/j.fbr.2016.09.002 · Cited by 61
Advances in Biomaterials for the Prevention and Disruption of Candida Biofilms
Vera‐González, N., & Shukla, A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.538602 · Cited by 61
Rat Indwelling Urinary Catheter Model of Candida albicans Biofilm Infection
Nett, J. E., Brooks, E. G., Cabezas-Olcoz, J., Sanchez, H., Zarnowski, R., Marchillo, K., & Andes, D. R. (2014) · Infection and Immunity · doi:10.1128/iai.02284-14 · Cited by 58
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 61
You, J., Du, L., King, J. B., Hall, B. E., & Cichewicz, R. H. (2013) · ACS Chemical Biology · doi:10.1021/cb400009f · Cited by 60
Monteiro, D. R., Takamiya, A. S., Feresin, L. P., Gorup, L. F., Camargo, E. R., Delbem, A. C. B., Henriques, M., & Barbosa, D. B. (2014) · Journal of Prosthodontic Research · doi:10.1016/j.jpor.2014.07.004 · Cited by 58
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them
Hadjifrangiskou, M., & Brannon, J. R. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s98939 · Cited by 58
How structured yeast multicellular communities live, age and die?
Váchová, L., & Palková, Z. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy033 · Cited by 58
Ecology and evolution of antibiotic persistence
Verstraete, L., den Bergh, B. V., Verstraeten, N., & Michiels, J. J. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.10.001 · Cited by 61
The toxin-antitoxin systemtisB-istR1
Wagner, E. G. H., & Unoson, C. (2012) · RNA Biology · doi:10.4161/rna.22578 · Cited by 56
Chong, P. P., Chin, V. K., Wong, W. F., Madhavan, P., Yong, P. V. C., & Looi, C. Y. (2018) · Genes · doi:10.3390/genes9110540 · Cited by 59
Wang, C., Hou, J., van der Mei, H. C., Busscher, H. J., & Ren, Y. (2019) · mBio · doi:10.1128/mbio.01908-19 · Cited by 55
Tsang, C. S. P., Ng, H., & McMillan, A. S. (2007) · Clinical Oral Investigations · doi:10.1007/s00784-007-0122-3 · Cited by 55
de Alteriis, E., Maione, A., Falanga, A., Bellavita, R., Galdiero, S., Albarano, L., Salvatore, M. M., Galdiero, E., & Guida, M. (2021) · Antibiotics · doi:10.3390/antibiotics11010026 · Cited by 54
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 58
Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Hasenoehrl, E., Wiggins, T. J., & Berney, M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.611683 · Cited by 54
Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All
Kean, R., Delaney, C., Rajendran, R., Sherry, L., Metcalfe, R., Thomas, R., McLean, W., Williams, C., & Ramage, G. (2018) · Journal of Fungi · doi:10.3390/jof4010012 · Cited by 56
Active efflux in dormant bacterial cells – New insights into antibiotic persistence
Pu, Y., Ke, Y., & Bai, F. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.11.002 · Cited by 52
Anti-Biofilm Strategies: How to Eradicate Candida Biofilms?
Bink, A. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010029 · Cited by 51
Phenotypic Diversification of Microbial Pathogens—Cooperating and Preparing for the Future
Schröter, L., & Dersch, P. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.06.024 · Cited by 51
Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans
Watamoto, T., Samaranayake, L. P., Jayatilake, J. A. M. S., Egusa, H., Yatani, H., & Seneviratne, C. J. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.03.008 · Cited by 53
Vera‐González, N., Bailey‐Hytholt, C. M., Langlois, L., Ribeiro, F. D. C., Santos, E. L. D. S., Junqueira, J. C., & Shukla, A. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36984 · Cited by 49
Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms
Nailis, H., Vandenbosch, D., Deforce, D. L. D., Nelis, H. J. C. F., & Coenye, T. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.02.004 · Cited by 49
Environmental, mechanistic and evolutionary landscape of antibiotic persistence
Bollen, C., Louwagie, E., Verstraeten, N., Michiels, J. J., & Ruelens, P. (2023) · EMBO Reports · doi:10.15252/embr.202357309 · Cited by 52
Response of sessile cells to stress: from changes in gene expression to phenotypic adaptation
Coenye, T. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00682.x · Cited by 53
Jasmann, J. R., Gedalanga, P. B., Borch, T., Mahendra, S., & Blotevogel, J. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b03134 · Cited by 48
Harrison, J. J., Turner, R. J., & Ceri, H. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00745.x · Cited by 47
Biofilms 2007: Broadened Horizons and New Emphases
Palmer, R. J., Jr., & Stoodley, P. (2007) · Journal of Bacteriology · doi:10.1128/jb.00787-07 · Cited by 48
Yeast cell differentiation: Lessons from pathogenic and non-pathogenic yeasts
Palková, Z., & Váchová, L. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.04.006 · Cited by 48
Rodrigues, C. F., & Henriques, M. (2017) · Pathogens · doi:10.3390/pathogens6040062 · Cited by 48
Fungicide-tolerant persister formation during cryptococcal pulmonary infection
Ke, W., Xie, Y., Chen, Y., Ding, H., Ye, L., Qiu, H., Li, H., Zhang, L., Chen, L., Tian, X., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2023.12.012 · Cited by 45
Truong, T., Zeng, G., Qingsong, L., Kwang, L. T., Tong, C., Chan, F. Y., Wang, Y., & Seneviratne, C. J. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.061523 · Cited by 45
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge
Roudbary, M., Vahedi‐Shahandashti, R., dos Santos, A. L. S., Mohammadi, S. R., Aslani, P., Lass‐Flörl, C., & Rodrigues, C. F. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1950121 · Cited by 46
Shinde, R. B., Raut, J. S., & Karuppayil, S. M. (2011) · Mycoscience · doi:10.1007/s10267-011-0155-y · Cited by 45
Aging and differentiation in yeast populations: elders with different properties and functions
Palková, Z., Wilkinson, D., & Váchová, L. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12103 · Cited by 45
Yang, S., Hay, I. D., Cameron, D. R., Speir, M., Cui, B., Su, F., Peleg, A. Y., Lithgow, T. J., Deighton, M. A., & Qu, Y. (2015) · Scientific Reports · doi:10.1038/srep18578 · Cited by 45
Bojsen, R., Regenberg, B., Gresham, D., & Folkesson, A. (2016) · Scientific Reports · doi:10.1038/srep21874 · Cited by 42
Ahmadi, M. S., Lee, H. H., Sanchez, D. A., Friedman, A. J., Tar, M. T., Davies, K. P., Nosanchuk, J. D., & Martinez, L. R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02659-15 · Cited by 41
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 44
Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates
Alvendal, C., Mohanty, S., Bohm‐Starke, N., & Brauner, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238428 · Cited by 41
Metadata
- Authors
- LaFleur, M. D., Kumamoto, C. A., & Lewis, K.
- Affiliations
- Northeastern University (US)
- Tufts University (US)
- Corresponding author
- Lewis, Kim
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-11
- Volume
- 50
- Issue
- 11
- Pages
- 3839-3846
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1635216
- OpenAlex
- W2135493487
- Cited by
- 521
- References
- 52
- Citations by year
- 2026: 26 · 2025: 29 · 2024: 20 · 2023: 20 · 2022: 20 · 2021: 39 · 2020: 33 · 2019: 21 · 2018: 22 · 2017: 41 · 2016: 34 · 2015: 39 · 2014: 25 · 2013: 31 · 2012: 26
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Tufts University School of Medicine
- National Institute of General Medical Sciences (R01GM061162)
- National Institute of Allergy and Infectious Diseases (AI052805, R01AI052805)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, biofilm, persister cells, antifungal tolerance, multidrug tolerance, amphotericin B, chlorhexidine, phenotypic variants, biofilm formation, cell attachment, dormancy, antifungal resistance
- MeSH terms
- Antifungal Agents, Candida albicans, Chlorhexidine, Disinfectants, Fluoresceins, Microbial Sensitivity Tests, Microscopy, Fluorescence, Phenotype, Biofilms, Drug Resistance, Multiple, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
